| Study | Pathogen | Total £ S1 | Total £ S2 | Total QALYs S1 | Total QALYs S2 | Inc costs | Inc QALYs | ICER |
|---|---|---|---|---|---|---|---|---|
| NHS Estates 2005 costs (single rooms cost an additional £10/night relative to beds in shared rooms) | ||||||||
| Chen 2001 | Intermittent BCC | £1,113,792 | £1,316,823 | 211.72 | 210.83 | −£203,031 | 0.89 | Dominant |
| France 2008 | Intermittent BCC | £985,541 | £1,357,488 | 212.18 | 210.69 | −£371,947 | 1.49 | Dominant |
| 50% uplift (beds in shared rooms £275/night versus single rooms £413/night) | ||||||||
| Chen 2001 | Intermittent BCC | £1,678,452 | £1,316,823 | 211.72 | 210.83 | £361,629 | 0.89 | £406,154 |
| France 2008 | Intermittent BCC | £1,550,201 | £1,357,488 | 212.18 | 210.69 | £192,713 | 1.49 | £129,218 |
| 25% uplift (beds in shared rooms £275/night versus single rooms £344/night) | ||||||||
| Chen 2001 | Intermittent BCC | £1,373,627 | £1,316,823 | 211.72 | 210.83 | £56,804 | 0.89 | £63,798 |
| France 2008 | Intermittent BCC | £1,245,376 | £1,357,488 | 212.18 | 210.69 | −£112,112 | 1.49 | Dominant |
BCC, B cepacia complex; ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life years; S1, new strategy; S2, old strategy
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.